Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Post-Radioiodine Treatment Whole Body Scan in the Era of Fluorodesoxyglucose Positron Emission Tomography for Differentiated Thyroid Carcinoma with elevated serum thyroglobulin levels.

Leboulleux S, El Bez I, Borget I, Elleuch M, Deandreis D, Al Ghuzlan A, Chougnet CN, Bidault F, Mirghani H, Lumbroso J, Hartl DM, Baudin E, Schlumberger M.

Thyroid. 2012 Jun 5. [Epub ahead of print]

PMID:
22667339
[PubMed - as supplied by publisher]
2.

Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels.

Leboulleux S, El Bez I, Borget I, Elleuch M, Déandreis D, Al Ghuzlan A, Chougnet C, Bidault F, Mirghani H, Lumbroso J, Hartl D, Baudin E, Schlumberger M.

Thyroid. 2012 Aug;22(8):832-8. doi: 10.1089/thy.2012.0081.

PMID:
22853728
[PubMed - indexed for MEDLINE]
3.

Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.

Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M.

Q J Nucl Med Mol Imaging. 2008 Mar;52(1):2-8.

PMID:
17538522
[PubMed - indexed for MEDLINE]
Free Article
4.

Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.

Na SJ, Yoo IeR, O JH, Lin C, Lin Q, Kim SH, Chung SK.

Ann Nucl Med. 2012 Jan;26(1):26-34. doi: 10.1007/s12149-011-0536-5. Epub 2011 Oct 5.

PMID:
21971605
[PubMed - indexed for MEDLINE]
5.
6.

Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.

Küçük ON, Gültekin SS, Aras G, Ibiş E.

Nucl Med Commun. 2006 Mar;27(3):261-6.

PMID:
16479246
[PubMed - indexed for MEDLINE]
7.
8.

Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.

Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL.

Ann Surg Oncol. 2008 Jan;15(1):286-92. Epub 2007 Sep 20.

PMID:
17882493
[PubMed - indexed for MEDLINE]
9.

Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis.

Dong MJ, Liu ZF, Zhao K, Ruan LX, Wang GL, Yang SY, Sun F, Luo XG.

Nucl Med Commun. 2009 Aug;30(8):639-50. doi: 10.1097/MNM.0b013e32832dcfa7.

PMID:
19512954
[PubMed - indexed for MEDLINE]
10.

Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma.

Zuijdwijk MD, Vogel WV, Corstens FH, Oyen WJ.

Nucl Med Commun. 2008 Jul;29(7):636-41. doi: 10.1097/MNM.0b013e3282f813e1.

PMID:
18528186
[PubMed - indexed for MEDLINE]
11.

Utility of 8F-FDG PET/CT in well differentiated thyroid carcinoma with high serum antithyroglobulin antibody.

Kingpetch K, Pipatrattana R, Tepmongkol S, Sirisalipoch S, Chaiwatanarat T.

J Med Assoc Thai. 2011 Oct;94(10):1238-44.

PMID:
22145510
[PubMed - indexed for MEDLINE]
12.

Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.

Kim MH, O JH, Ko SH, Bae JS, Lim DJ, Kim SH, Baek KH, Lee JM, Kang MI, Cha BY, Lee KW.

Thyroid. 2012 Feb;22(2):157-64. doi: 10.1089/thy.2011.0177. Epub 2012 Jan 6.

PMID:
22224820
[PubMed - indexed for MEDLINE]
13.

Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?

Bannas P, Derlin T, Groth M, Apostolova I, Adam G, Mester J, Klutmann S.

Ann Nucl Med. 2012 Jan;26(1):77-85. doi: 10.1007/s12149-011-0545-4. Epub 2011 Oct 19.

PMID:
22006540
[PubMed - indexed for MEDLINE]
14.

Complementary role of 18F-fluorodeoxyglucose positron emission tomography and 131I scan in the follow-up of post-therapy differentiated thyroid cancer.

Hsu CH, Liu RS, Wu CH, Chen SM, Shih LS.

J Formos Med Assoc. 2002 Jul;101(7):459-67.

PMID:
12353337
[PubMed - indexed for MEDLINE]
15.

Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT.

Seo JH, Lee SW, Ahn BC, Lee J.

Clin Endocrinol (Oxf). 2010 Apr;72(4):558-63. doi: 10.1111/j.1365-2265.2009.03693.x. Epub 2009 Sep 10.

PMID:
19744107
[PubMed - indexed for MEDLINE]
16.
17.

The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels.

Ozkan E, Soydal C, Araz M, Aras G, Ibis E.

Clin Nucl Med. 2012 Aug;37(8):755-8. doi: 10.1097/RLU.0b013e31825ae77b.

PMID:
22785502
[PubMed - indexed for MEDLINE]
18.

18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.

Shammas A, Degirmenci B, Mountz JM, McCook BM, Branstetter B, Bencherif B, Joyce JM, Carty SE, Kuffner HA, Avril N.

J Nucl Med. 2007 Feb;48(2):221-6. Erratum in: J Nucl Med. 2007 Mar;48(3):412. Bencherif, Badreddine B [corrected to Bencherif, Badreddine].

PMID:
17268018
[PubMed - indexed for MEDLINE]
Free Article
19.

Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer.

Oh JR, Byun BH, Hong SP, Chong A, Kim J, Yoo SW, Kang SR, Kim DY, Song HC, Bom HS, Min JJ.

Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1459-68. doi: 10.1007/s00259-011-1809-x. Epub 2011 Apr 20.

PMID:
21505897
[PubMed - indexed for MEDLINE]
20.

Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET.

Freudenberg LS, Antoch G, Frilling A, Jentzen W, Rosenbaum SJ, Kühl H, Bockisch A, Görges R.

Eur J Nucl Med Mol Imaging. 2008 May;35(5):950-7. doi: 10.1007/s00259-007-0634-8. Epub 2008 Jan 12.

PMID:
18193222
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk